Stephen P. Carey - 02 Jul 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Reporting relationship: SVP & CFO
Issuer ticker: ANIP
Reported as of: 02 Jul 2026
Net transaction value: -$284,918
SEC form: 4
Accepted by SEC: 06 Jul 2026, 21:40:18 UTC
Prior SEC filing: 30 Jun 2026
Next SEC filing: 30 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook

Key filing fact

Stephen P. Carey filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 06 Jul 2026.

Key facts

This page summarizes Stephen P. Carey's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jul 2026, 21:40.

Change

Previous filing in this sequence was filed on 30 Jun 2026.
Current net transaction value: -$284,918.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001674236 Primary reporting owner

CAREY STEPHEN P.

Relationship: SVP & CFO
Address: C/O ANI PHARMACEUTICALS, INC., 104 CARNEGIE CENTER, SUITE 300, PRINCETON
Signature: /s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,313
Change %: +1.9%
Price: $49.51^*
Shares after: 180,856
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1

ANIP transaction

Common Stock

Sale

Transaction value: $284,918
Shares: -3,313
Change %: -1.8%
Price: $86.00
Shares after: 177,543
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANIP transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -3,313
Change %: -50%
Price: $49.51^*
Shares after: 3,313
Date: 02 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,313
Exercise price: $49.51
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

Footnote F2

25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.